(Q40105829)

English

The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

author name string

J Golay

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

L Cuppini

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

F Leoni

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

C Micò

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

V Barbui

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

M Domenghini

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

L Lombardi

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

A Neri

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

A M Barbui

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

A Salvi

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

P Pozzi

11

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

G Porro

12

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

P Pagani

13

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

G Fossati

14

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

P Mascagni

15

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

M Introna

16

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

A Rambaldi

17

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

19 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1892-1900

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404860

0 references

Histone deacetylases (HDACs): characterization of the classical HDAC family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenetic aspects of differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospects: histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular pathogenesis of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoid receptors in health and disease: co-regulators and the chromatin connection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment of human acute myelogenous leukemia lines secreting interleukin-1β in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33 acute lymphoblastic leukaemias in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors: insights into mechanisms of lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential protein acetylation induced by novel histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404860

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404860

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40105829&oldid=1885371299"